2.5g Vitamin C daily for cancer patients with radiotherapy-resistant bone metastases

Study looked at 39 patients with bone metastases previously treated with radiotherapy. All patients were radiotherapy-resistant.

A median reduction of 50% in pain was observed among the patients in the vitamin C group.

2.5g vitamin C infusion daily saw a median survival time of 10 months whereas the chemotherapy and control groups experienced a median survival of just 2 months.

2.5g vitamin C infusion daily reduced pain in patients in comparison to other patients who did not receive it.

2.5g vitamin C infusion increased patient performance.

To reach the 2.5g levels used in this study I take half a tablespoon or 7.5ml a day of the highest strength Liposomal Vitamin C.

Each 200ml bottle of the highest strength Liposomal Vitamin C contains 26 days of 2.5g vitamin C doses as mentioned in the study.

www.highdosevitaminc.com.au/shop